The validation of low-dose CT scans from the [(18)F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans

PURPOSE: Radiologically defined sarcopenia, or a low skeletal muscle index (SMI), is an emerging biomarker for adverse clinical outcomes in head and neck cancer (HNC) patients. Recently, SMI measurements have been validated at the level of the third cervical vertebra (C3) on diagnostic neck CT scans...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwart, Aniek T., Cavalheiro, Vitor J., Lamers, Maria J., Dierckx, Rudi A. J. O., de Bock, Geertruida H., Halmos, Gyorgy B., van der Hoorn, Anouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119057/
https://www.ncbi.nlm.nih.gov/pubmed/36781423
http://dx.doi.org/10.1007/s00259-023-06117-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119057/
https://www.ncbi.nlm.nih.gov/pubmed/36781423
http://dx.doi.org/10.1007/s00259-023-06117-3

Ejemplares similares